<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08623350</doc-number>
<kind>B1</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>60</s160>
</s100>
<s200>
<s210>1</s210>
<s211>36</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 1
Pro Ala Ala Ala Thr Val Thr Lys Lys Val Ala Lys Ser Pro Lys Lys
1               5                   10                  15
Ala Lys Ala Ala Lys Pro Lys Lys Ala Ala Lys Ser Ala Ala Lys Ala
            20                  25                  30
Val Lys Pro Lys
        35
</s400>
<s200>
<s210>2</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 2
Thr Lys Lys Val Ala Lys Arg Pro Arg Ala Lys Arg Ala Ala
1               5                   10
</s400>
<s200>
<s210>3</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 3
Thr Lys Lys Val Ala Lys Arg Pro Arg Ala Lys Arg Asp Leu
1               5                   10
</s400>
<s200>
<s210>4</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 4
Gly Lys Arg Pro Arg Ala Lys Arg Ala
1               5
</s400>
<s200>
<s210>5</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 5
Cys Lys Arg Pro Arg Ala Lys Arg Asp Leu
1               5                   10
</s400>
<s200>
<s210>6</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 6
Cys Val Ala Lys Arg Pro Arg Ala Lys Arg Asp Leu
1               5                   10
</s400>
<s200>
<s210>7</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 7
Cys Lys Lys Val Ala Lys Arg Pro Arg Ala Lys Arg Asp Leu
1               5                   10
</s400>
<s200>
<s210>8</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 8
Arg Arg Arg Arg Arg Arg
1               5
</s400>
<s200>
<s210>9</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>KALLIKREIN 2 INHIBITOR</s223>
</s220>
</s200>
<s400> 9
Ser Arg Phe Lys Val Trp Trp Ala Ala Gly
1               5                   10
</s400>
<s200>
<s210>10</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>KALLIKREIN 2 INHIBITOR</s223>
</s220>
</s200>
<s400> 10
Ala Ala Arg Arg Pro Phe Pro Ala Pro Ser
1               5                   10
</s400>
<s200>
<s210>11</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>KALLIKREIN 2 INHIBITOR</s223>
</s220>
</s200>
<s400> 11
Pro Ala Arg Arg Pro Phe Pro Val Thr Ala
1               5                   10
</s400>
<s200>
<s210>12</s210>
<s211>56</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TISSUE PROTEASE INHIBITOR</s223>
</s220>
</s200>
<s400> 12
Asp Ser Leu Gly Arg Glu Ala Lys Cys Tyr Asn Glu Leu Asn Gly Cys
1               5                   10                  15
Thr Lys Ile Tyr Asp Pro Val Cys Gly Thr Asp Gly Asn Thr Tyr Pro
            20                  25                  30
Asn Glu Cys Val Leu Cys Phe Glu Asn Arg Lys Arg Gln Thr Ser Ile
        35                  40                  45
Leu Ile Gln Lys Ser Gly Pro Cys
    50                  55
</s400>
<s200>
<s210>13</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETING PEPTIDE CG-BETA</s223>
</s220>
</s200>
<s400> 13
Ser Tyr Ala Val Ala Leu Ser Cys Gln Cys Ala Leu Cys Arg Arg
1               5                   10                  15
</s400>
<s200>
<s210>14</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETING PEPTIDE CG-BETA (ALA TRUNCATION)</s223>
</s220>
</s200>
<s400> 14
Ala Val Ala Leu Ser Cys Gln Cys Ala Leu Cys Arg Arg
1               5                   10
</s400>
<s200>
<s210>15</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>LHRH</s223>
</s220>
</s200>
<s400> 15
Glu His Trp Ser Tyr Gly Leu Arg Pro Gly
1               5                   10
</s400>
<s200>
<s210>16</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>SOMATOSTATIN OCTAPEPTIDE RC-121</s223>
</s220>
</s200>
<s400> 16
Phe Cys Tyr Trp Lys Val Cys Thr
1               5
</s400>
<s200>
<s210>17</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>PROAPOPTOTIC PEPTIDE</s223>
</s220>
</s200>
<s400> 17
Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Leu Lys Leu Ala
1               5                   10
</s400>
<s200>
<s210>18</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>Escherichia coli</s213>
</s200>
<s400> 18
Asn Ser Ser Asn Tyr Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr
1               5                   10                  15
Gly Cys Tyr
</s400>
<s200>
<s210>19</s210>
<s211>61</s211>
<s212>PRT</s212>
<s213>Escherichia coli</s213>
</s200>
<s400> 19
Val Leu Ser Phe Ser Pro Phe Ala Gln Asp Ala Lys Pro Val Glu Ser
1               5                   10                  15
Ser Lys Glu Lys Ile Thr Leu Glu Ser Lys Lys Cys Asn Ile Ala Lys
            20                  25                  30
Lys Ser Asn Lys Ser Asp Pro Glu Ser Met Asn Ser Ser Asn Tyr Cys
        35                  40                  45
Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr
    50                  55                  60
</s400>
<s200>
<s210>20</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETS V-BETA3 INTEGRIN</s223>
</s220>
</s200>
<s400> 20
Cys Asp Cys Arg Gly Asp Cys Phe Cys
1               5
</s400>
<s200>
<s210>21</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>N-TERMINAL TRUNCATION OF GASTRIN</s223>
</s220>
</s200>
<s400> 21
Met Gly Trp Met Asp Phe
1               5
</s400>
<s200>
<s210>22</s210>
<s211>27</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>GASTRIN RELEASING PEPTIDE</s223>
</s220>
</s200>
<s400> 22
Val Pro Leu Pro Ala Gly Gly Gly Thr Val Leu Thr Lys Met Tyr Pro
1               5                   10                  15
Arg Gly Asn His Trp Ala Val Gly His Leu Met
            20                  25
</s400>
<s200>
<s210>23</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETS AML</s223>
</s220>
</s200>
<s400> 23
Cys Ala Tyr His Leu Arg Arg Cys
1               5
</s400>
<s200>
<s210>24</s210>
<s211>3</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>LYMPH NODE HOMING</s223>
</s220>
</s200>
<s400> 24
Cys Ala Tyr
1
</s400>
<s200>
<s210>25</s210>
<s211>4</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CELL PENETRATING</s223>
</s220>
</s200>
<s400> 25
Arg Leu Arg Arg
1
</s400>
<s200>
<s210>26</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETS COLONIC DYSPLASIA</s223>
</s220>
</s200>
<s400> 26
Val Arg Pro Met Pro Leu Gln
1               5
</s400>
<s200>
<s210>27</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>BINDS IRRADIATED TUMORS</s223>
</s220>
</s200>
<s400> 27
His Val Gly Gly Ser Ser Val
1               5
</s400>
<s200>
<s210>28</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>BINDS MEMBRANE DIPEPTIDASE (MDP)</s223>
</s220>
</s200>
<s400> 28
Cys Gly Phe Glu Cys Val Arg Gln Cys Pro Glu Arg Cys
1               5                   10
</s400>
<s200>
<s210>29</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETS MURINE PROSTATE VASCULATURE</s223>
</s220>
</s200>
<s400> 29
Ser Met Ser Ile Ala Arg Leu
1               5
</s400>
<s200>
<s210>30</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>TARGETS MURINE PROSTATE VASCULATURE</s223>
</s220>
</s200>
<s400> 30
Val Ser Phe Leu Glu Tyr Arg
1               5
</s400>
<s200>
<s210>31</s210>
<s211>32</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FRAGMENT OF THE HIGH MOBILITY GROUP (HMG) N2</s223>
</s220>
</s200>
<s400> 31
Cys Lys Asp Glu Pro Gln Arg Arg Ser Ala Arg Leu Ser Ala Lys Pro
1               5                   10                  15
Ala Pro Pro Lys Pro Glu Pro Lys Pro Lys Lys Ala Pro Ala Lys Lys
            20                  25                  30
 
</s400>
<s200>
<s210>32</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>VEGF BINDING PEPTIDE</s223>
</s220>
</s200>
<s400> 32
Val Glu Pro Asn Cys Asp Ile His Val Met Trp Glu Trp Glu Cys Phe
1               5                   10                  15
Glu Arg Leu
</s400>
<s200>
<s210>33</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>NASOPHYRINGIAL DERIV ED L-PEPTIDE, CAUSES
      INTERNALIZATION OF PHAGE</s223>
</s220>
</s200>
<s400> 33
Arg Leu Leu Asp Thr Asn Arg Pro Leu Leu Pro Tyr
1               5                   10
</s400>
<s200>
<s210>34</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>RGDLATL TRUNCATED, TARGETS ALPHA(V) BETA(6)
      INTEGRIN</s223>
</s220>
</s200>
<s400> 34
Arg Gly Asp Leu Ala Thr Leu Arg Gln Leu Ala Gln Glu Asp Gly Val
1               5                   10                  15
Val Gly Val Arg
            20
</s400>
<s200>
<s210>35</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 35
Met Ala Gln Asp Ile Ile Ser Thr Ile Ser Asp Leu Val Lys Trp Ile
1               5                   10                  15
Ile Asp Thr Val Asn Lys Phe Thr Lys Lys
            20                  25
</s400>
<s200>
<s210>36</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>Staphylococcus epidermidis</s213>
</s200>
<s400> 36
Met Met Ala Ala Asp Ile Ile Ser Thr Ile Gly Asp Leu Val Lys Trp
1               5                   10                  15
Ile Ile Asp Thr Val Asn Lys Phe Lys Lys
            20                  25
</s400>
<s200>
<s210>37</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 37
Met Ala Gln Asp Ile Ile Ser Thr Ile Ser Asp Leu Val Lys Trp Ile
1               5                   10                  15
Ile Asp Thr Val Asn Lys Phe Thr Lys Lys
            20                  25
</s400>
<s200>
<s210>38</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 38
Met Gly Ile Ile Ala Gly Ile Ile Lys Val Ile Lys Ser Leu Ile Glu
1               5                   10                  15
Gln Phe Thr Gly Lys
            20
</s400>
<s200>
<s210>39</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 39
Met Gly Ile Ile Ala Gly Ile Ile Lys Phe Ile Lys Gly Leu Ile Glu
1               5                   10                  15
Lys Phe Thr Gly Lys
            20
</s400>
<s200>
<s210>40</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 40
Met Glu Phe Val Ala Lys Leu Phe Lys Phe Phe Lys Asp Leu Leu Gly
1               5                   10                  15
Lys Phe Leu Gly Asn Asn
            20
</s400>
<s200>
<s210>41</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 41
Met Ala Ile Val Gly Thr Ile Ile Lys Ile Ile Lys Ala Ile Ile Asp
1               5                   10                  15
Ile Phe Ala Lys
            20
</s400>
<s200>
<s210>42</s210>
<s211>44</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 42
Met Glu Gly Leu Phe Asn Ala Ile Lys Asp Thr Val Thr Ala Ala Ile
1               5                   10                  15
Asn Asn Asp Gly Ala Lys Leu Gly Thr Ser Ile Val Ser Ile Val Glu
            20                  25                  30
Asn Gly Val Gly Leu Leu Gly Lys Leu Phe Gly Phe
        35                  40
</s400>
<s200>
<s210>43</s210>
<s211>44</s211>
<s212>PRT</s212>
<s213>Staphylococcus aureus</s213>
</s200>
<s400> 43
Met Thr Gly Leu Ala Glu Ala Ile Ala Asn Thr Val Gln Ala Ala Gln
1               5                   10                  15
Gln His Asp Ser Val Lys Leu Gly Thr Ser Ile Val Asp Ile Val Ala
            20                  25                  30
Asn Gly Val Gly Leu Leu Gly Lys Leu Phe Gly Phe
        35                  40
</s400>
<s200>
<s210>44</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>M13pIII N-TERMINAL SEQUENCE</s223>
</s220>
</s200>
<s400> 44
Met Lys Lys Leu Leu Phe Ala Ile Pro Leu Val Val Pro Phe Tyr Ser
1               5                   10                  15
His Ser
</s400>
<s200>
<s210>45</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 45
Gly Lys Arg Pro Arg Ala Lys Arg Ala
1               5
</s400>
<s200>
<s210>46</s210>
<s211>60</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>C-TERMINAL SIGNAL SEQUENCE OF hly-A</s223>
</s220>
</s200>
<s400> 46
Ser Thr Tyr Gly Ser Gln Asp Tyr Leu Asn Pro Leu Ile Asn Glu Ile
1               5                   10                  15
Ser Lys Ile Ile Ser Ala Ala Gly Asn Leu Asp Val Lys Glu Glu Arg
            20                  25                  30
Ser Ala Ala Ser Leu Leu Gln Leu Ser Gly Asn Ala Ser Asp Phe Ser
        35                  40                  45
Tyr Gly Arg Asn Ser Ile Thr Leu Thr Ala Ser Ala
    50                  55                  60
</s400>
<s200>
<s210>47</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 47
Gly Lys Arg Pro Arg Ala Lys Arg Ala
1               5
</s400>
<s200>
<s210>48</s210>
<s211>60</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>C-TERMINAL SIGNAL SEQUENCE OF hlyA</s223>
</s220>
</s200>
<s400> 48
Ser Thr Tyr Gly Ser Gln Asp Tyr Leu Asn Pro Leu Ile Asn Glu Ile
1               5                   10                  15
Ser Lys Ile Ile Ser Ala Ala Gly Asn Leu Asp Val Lys Glu Glu Arg
            20                  25                  30
Ser Ala Ala Ser Leu Leu Gln Leu Ser Gly Asn Ala Ser Asp Phe Ser
        35                  40                  45
Tyr Gly Arg Asn Ser Ile Thr Leu Thr Ala Ser Ala
    50                  55                  60
</s400>
<s200>
<s210>49</s210>
<s211>85</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>IMMUNITY PROTEIN</s223>
</s220>
</s200>
<s400> 49
Met Gly Leu Lys Leu Asp Leu Thr Trp Phe Asp Lys Ser Thr Glu Asp
1               5                   10                  15
Phe Lys Gly Glu Glu Tyr Ser Lys Asp Phe Gly Asp Asp Gly Ser Val
            20                  25                  30
Met Glu Ser Leu Gly Val Pro Phe Lys Asp Asn Val Asn Asn Gly Cys
        35                  40                  45
Phe Asp Val Ile Ala Glu Trp Val Pro Leu Leu Gln Pro Tyr Phe Asn
    50                  55                  60
His Gln Ile Asp Ile Ser Asp Asn Glu Tyr Phe Val Ser Phe Asp Tyr
65                  70                  75                  80
Arg Asp Gly Asp Trp
                85
</s400>
<s200>
<s210>50</s210>
<s211>601</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CHIMERIC PATTERN
      M13pIII(18)-Ala-Gly-Gly-Gly-TGF-alpha(50)-M13pIII(372+)-C-terminus
      of colicin E3</s223>
</s220>
</s200>
<s400> 50
Met Lys Lys Leu Leu Phe Ala Ile Pro Leu Val Val Pro Phe Tyr Ser
1               5                   10                  15
His Ser Ala Gly Gly Gly Val Val Ser His Phe Asn Asp Cys Pro Asp
            20                  25                  30
Ser His Thr Gln Phe Cys Phe His Gly Thr Cys Arg Phe Leu Val Gln
        35                  40                  45
Glu Asp Lys Pro Ala Cys Val Cys His Ser Gly Tyr Val Gly Ala Arg
    50                  55                  60
Cys Glu His Ala Asp Leu Leu Ala Ala Glu Thr Val Glu Ser Cys Leu
65                  70                  75                  80
Ala Lys Ser His Thr Glu Asn Ser Phe Thr Asn Val Trp Lys Asp Asp
                85                  90                  95
Lys Thr Leu Asp Arg Tyr Ala Asn Tyr Glu Gly Cys Leu Trp Asn Ala
            100                 105                 110
Thr Gly Val Val Val Cys Thr Gly Asp Glu Thr Gln Cys Tyr Gly Thr
        115                 120                 125
Trp Val Pro Ile Gly Leu Ala Ile Pro Glu Asn Glu Gly Gly Gly Ser
    130                 135                 140
Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly Thr Lys
145                 150                 155                 160
Pro Pro Glu Tyr Gly Asp Thr Pro Ile Pro Gly Tyr Thr Tyr Ile Asn
                165                 170                 175
Pro Leu Asp Gly Thr Tyr Pro Pro Gly Thr Glu Gln Asn Pro Ala Asn
            180                 185                 190
Pro Asn Pro Ser Leu Glu Glu Ser Gln Pro Leu Asn Thr Phe Met Phe
        195                 200                 205
Gln Asn Asn Arg Phe Arg Asn Arg Gln Gly Ala Leu Thr Val Tyr Thr
    210                 215                 220
Gly Thr Val Thr Gln Gly Thr Asp Pro Val Lys Thr Tyr Tyr Gln Tyr
225                 230                 235                 240
Thr Pro Val Ser Ser Lys Ala Met Tyr Asp Ala Tyr Trp Asn Gly Lys
                245                 250                 255
Phe Arg Asp Cys Ala Phe His Ser Gly Phe Asn Glu Asp Leu Phe Val
            260                 265                 270
Cys Glu Tyr Gln Gly Gln Ser Ser Asp Leu Pro Gln Pro Pro Val Asn
        275                 280                 285
Ala Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Glu Gly Gly
    290                 295                 300
Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly
305                 310                 315                 320
Ser Gly Gly Gly Ser Gly Ser Gly Asp Phe Asp Tyr Glu Lys Met Ala
                325                 330                 335
Asn Ala Asn Lys Gly Ala Met Thr Glu Asn Ala Asp Glu Asn Ala Leu
            340                 345                 350
Gln Ser Asp Ala Lys Gly Lys Leu Asp Ser Val Ala Thr Asp Tyr Gly
        355                 360                 365
Ala Ala Ile Asp Gly Phe Ile Gly Asp Val Ser Gly Leu Ala Asn Gly
    370                 375                 380
Asn Gly Ala Thr Gly Asp Phe Ala Gly Ser Asn Ser Gln Met Ala Gln
385                 390                 395                 400
Val Gly Asp Gly Asp Asn Ser Pro Leu Met Asn Asn Phe Arg Gln Tyr
                405                 410                 415
Leu Pro Ser Leu Pro Gln Ser Val Glu Cys Arg Phe Ala His Asp Pro
            420                 425                 430
Met Ala Gly Gly His Arg Met Trp Gln Met Ala Gly Leu Lys Ala Gln
        435                 440                 445
Arg Ala Gln Thr Asp Val Asn Asn Lys Gln Ala Ala Phe Asp Ala Ala
    450                 455                 460
Ala Lys Glu Lys Ser Asp Ala Asp Ala Ala Leu Ser Ser Ala Met Glu
465                 470                 475                 480
Ser Arg Lys Lys Lys Glu Asp Lys Lys Arg Ser Ala Glu Asn Asn Leu
                485                 490                 495
Asn Asp Glu Lys Asn Lys Pro Arg Lys Gly Phe Lys Asp Tyr Gly His
            500                 505                 510
Asp Tyr His Pro Ala Pro Lys Thr Glu Asn Ile Lys Gly Leu Gly Asp
        515                 520                 525
Leu Lys Pro Gly Ile Pro Lys Thr Pro Lys Gln Asn Gly Gly Gly Lys
    530                 535                 540
Arg Lys Arg Trp Thr Gly Asp Lys Gly Arg Lys Ile Tyr Glu Trp Asp
545                 550                 555                 560
Ser Gln His Gly Glu Leu Glu Gly Tyr Arg Ala Ser Asp Gly Gln His
                565                 570                 575
Leu Gly Ser Phe Asp Pro Lys Thr Gly Asn Gln Leu Lys Gly Pro Asp
            580                 585                 590
Pro Lys Arg Asn Ile Lys Lys Tyr Leu
        595                 600
</s400>
<s200>
<s210>51</s210>
<s211>620</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CHIMERIC PROTEIN M13pIII-PSM-alpha-3-TGF-alpha</s223>
</s220>
</s200>
<s400> 51
Met Lys Lys Leu Leu Phe Ala Ile Pro Leu Val Val Pro Phe Tyr Ser
1               5                   10                  15
His Ser Ala Met Glu Phe Val Ala Lys Leu Phe Lys Phe Phe Lys Asp
            20                  25                  30
Leu Leu Gly Lys Phe Leu Gly Asn Asn Val Val Ser His Phe Asn Asp
        35                  40                  45
Cys Pro Asp Ser His Thr Gln Phe Cys Phe His Gly Thr Cys Arg Phe
    50                  55                  60
Leu Val Gln Glu Asp Lys Pro Ala Cys Val Cys His Ser Gly Tyr Val
65                  70                  75                  80
Gly Ala Arg Cys Glu His Ala Asp Leu Leu Ala Ala Glu Thr Val Glu
                85                  90                  95
Ser Cys Leu Ala Lys Ser His Thr Glu Asn Ser Phe Thr Asn Val Trp
            100                 105                 110
Lys Asp Asp Lys Thr Leu Asp Arg Tyr Ala Asn Tyr Glu Gly Cys Leu
        115                 120                 125
Trp Asn Ala Thr Gly Val Val Val Cys Thr Gly Asp Glu Thr Gln Cys
    130                 135                 140
Tyr Gly Thr Trp Val Pro Ile Gly Leu Ala Ile Pro Glu Asn Glu Gly
145                 150                 155                 160
Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly
                165                 170                 175
Gly Thr Lys Pro Pro Glu Tyr Gly Asp Thr Pro Ile Pro Gly Tyr Thr
            180                 185                 190
Tyr Ile Asn Pro Leu Asp Gly Thr Tyr Pro Pro Gly Thr Glu Gln Asn
        195                 200                 205
Pro Ala Asn Pro Asn Pro Ser Leu Glu Glu Ser Gln Pro Leu Asn Thr
    210                 215                 220
Phe Met Phe Gln Asn Asn Arg Phe Arg Asn Arg Gln Gly Ala Leu Thr
225                 230                 235                 240
Val Tyr Thr Gly Thr Val Thr Gln Gly Thr Asp Pro Val Lys Thr Tyr
                245                 250                 255
Tyr Gln Tyr Thr Pro Val Ser Ser Lys Ala Met Tyr Asp Ala Tyr Trp
            260                 265                 270
Asn Gly Lys Phe Arg Asp Cys Ala Phe His Ser Gly Phe Asn Glu Asp
        275                 280                 285
Leu Phe Val Cys Glu Tyr Gln Gly Gln Ser Ser Asp Leu Pro Gln Pro
    290                 295                 300
Pro Val Asn Ala Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser
305                 310                 315                 320
Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu
                325                 330                 335
Gly Gly Gly Ser Gly Gly Gly Ser Gly Ser Gly Asp Phe Asp Tyr Glu
            340                 345                 350
Lys Met Ala Asn Ala Asn Lys Gly Ala Met Thr Glu Asn Ala Asp Glu
        355                 360                 365
Asn Ala Leu Gln Ser Asp Ala Lys Gly Lys Leu Asp Ser Val Ala Thr
    370                 375                 380
Asp Tyr Gly Ala Ala Ile Asp Gly Phe Ile Gly Asp Val Ser Gly Leu
385                 390                 395                 400
Ala Asn Gly Asn Gly Ala Thr Gly Asp Phe Ala Gly Ser Asn Ser Gln
                405                 410                 415
Met Ala Gln Val Gly Asp Gly Asp Asn Ser Pro Leu Met Asn Asn Phe
            420                 425                 430
Arg Gln Tyr Leu Pro Ser Leu Pro Gln Ser Val Glu Cys Arg Phe Ala
        435                 440                 445
His Asp Pro Met Ala Gly Gly His Arg Met Trp Gln Met Ala Gly Leu
    450                 455                 460
Lys Ala Gln Arg Ala Gln Thr Asp Val Asn Asn Lys Gln Ala Ala Phe
465                 470                 475                 480
Asp Ala Ala Ala Lys Glu Lys Ser Asp Ala Asp Ala Ala Leu Ser Ser
                485                 490                 495
Ala Met Glu Ser Arg Lys Lys Lys Glu Asp Lys Lys Arg Ser Ala Glu
            500                 505                 510
Asn Asn Leu Asn Asp Glu Lys Asn Lys Pro Arg Lys Gly Phe Lys Asp
        515                 520                 525
Tyr Gly His Asp Tyr His Pro Ala Pro Lys Thr Glu Asn Ile Lys Gly
    530                 535                 540
Leu Gly Asp Leu Lys Pro Gly Ile Pro Lys Thr Pro Lys Gln Asn Gly
545                 550                 555                 560
Gly Gly Lys Arg Lys Arg Trp Thr Gly Asp Lys Gly Arg Lys Ile Tyr
                565                 570                 575
Glu Trp Asp Ser Gln His Gly Glu Leu Glu Gly Tyr Arg Ala Ser Asp
            580                 585                 590
Gly Gln His Leu Gly Ser Phe Asp Pro Lys Thr Gly Asn Gln Leu Lys
        595                 600                 605
Gly Pro Asp Pro Lys Arg Asn Ile Lys Lys Tyr Leu
    610                 615                 620
</s400>
<s200>
<s210>52</s210>
<s211>395</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CHIMERIC PROTEIN CYTOLETHAL DISTINDING TOXIN
      CLTDB FUSION WITH APOPTIN</s223>
</s220>
</s200>
<s400> 52
Met Lys Lys Tyr Ile Ile Ser Leu Ile Val Phe Leu Ser Phe Tyr Ala
1               5                   10                  15
Gln Ala Asp Leu Thr Asp Phe Arg Val Ala Thr Trp Asn Leu Gln Gly
            20                  25                  30
Ala Ser Ala Thr Thr Glu Ser Lys Trp Asn Ile Asn Val Arg Gln Leu
        35                  40                  45
Ile Ser Gly Glu Asn Ala Val Asp Ile Leu Ala Val Gln Glu Ala Gly
    50                  55                  60
Ser Pro Pro Ser Thr Ala Val Asp Thr Gly Thr Leu Ile Pro Ser Pro
65                  70                  75                  80
Gly Ile Pro Val Arg Glu Leu Ile Trp Asn Leu Ser Thr Asn Ser Arg
                85                  90                  95
Pro Gln Gln Val Tyr Ile Tyr Phe Ser Ala Val Asp Ala Leu Gly Gly
            100                 105                 110
Arg Val Asn Leu Ala Leu Val Ser Asn Arg Arg Ala Asp Glu Val Phe
        115                 120                 125
Val Leu Ser Pro Val Arg Gln Gly Gly Arg Pro Leu Leu Gly Ile Arg
    130                 135                 140
Ile Gly Asn Asp Ala Phe Phe Thr Ala His Ala Ile Ala Met Arg Asn
145                 150                 155                 160
Asn Asp Ala Pro Ala Leu Val Glu Glu Val Tyr Asn Phe Phe Arg Asp
                165                 170                 175
Ser Arg Asp Pro Val His Gln Ala Leu Asn Trp Met Ile Leu Gly Asp
            180                 185                 190
Phe Asn Arg Glu Pro Ala Asp Leu Glu Met Asn Leu Thr Val Pro Val
        195                 200                 205
Arg Arg Ala Ser Glu Ile Ile Ser Pro Ala Ala Ala Thr Gln Thr Ser
    210                 215                 220
Gln Arg Thr Leu Asp Tyr Ala Val Ala Gly Asn Ser Val Ala Phe Arg
225                 230                 235                 240
Pro Ser Pro Leu Gln Ala Gly Ile Val Tyr Gly Ala Arg Arg Thr Gln
                245                 250                 255
Ile Ser Ser Asp His Phe Pro Val Gly Val Ser Arg Arg Gly Gly Gly
            260                 265                 270
Gly Gly Met Asn Ala Leu Gln Glu Asp Thr Pro Pro Gly Pro Ser Thr
        275                 280                 285
Val Phe Arg Pro Pro Thr Ser Ser Arg Pro Leu Glu Thr Pro His Cys
    290                 295                 300
Arg Glu Ile Arg Ile Gly Ile Ala Gly Ile Thr Ile Thr Leu Ser Leu
305                 310                 315                 320
Cys Gly Cys Ala Asn Ala Arg Ala Pro Thr Leu Arg Ser Ala Thr Ala
                325                 330                 335
Asp Asn Ser Glu Ser Thr Gly Phe Lys Asn Val Pro Asp Leu Arg Thr
            340                 345                 350
Asp Gln Pro Lys Pro Pro Ser Lys Lys Arg Ser Cys Asp Pro Ser Glu
        355                 360                 365
Tyr Arg Val Ser Glu Leu Lys Glu Ser Leu Ile Thr Thr Thr Pro Ser
    370                 375                 380
Arg Pro Arg Thr Ala Lys Arg Arg Ile Arg Leu
385                 390                 395
</s400>
<s200>
<s210>53</s210>
<s211>370</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CHIMERIC PROTEIN CYTOLETHAL DISTINDING TOXIN
      CLTDB FUSION WITH A TRUNCATED APOPTIN</s223>
</s220>
</s200>
<s400> 53
Met Lys Lys Tyr Ile Ile Ser Leu Ile Val Phe Leu Ser Phe Tyr Ala
1               5                   10                  15
Gln Ala Asp Leu Thr Asp Phe Arg Val Ala Thr Trp Asn Leu Gln Gly
            20                  25                  30
Ala Ser Ala Thr Thr Glu Ser Lys Trp Asn Ile Asn Val Arg Gln Leu
        35                  40                  45
Ile Ser Gly Glu Asn Ala Val Asp Ile Leu Ala Val Gln Glu Ala Gly
    50                  55                  60
Ser Pro Pro Ser Thr Ala Val Asp Thr Gly Thr Leu Ile Pro Ser Pro
65                  70                  75                  80
Gly Ile Pro Val Arg Glu Leu Ile Trp Asn Leu Ser Thr Asn Ser Arg
                85                  90                  95
Pro Gln Gln Val Tyr Ile Tyr Phe Ser Ala Val Asp Ala Leu Gly Gly
            100                 105                 110
Arg Val Asn Leu Ala Leu Val Ser Asn Arg Arg Ala Asp Glu Val Phe
        115                 120                 125
Val Leu Ser Pro Val Arg Gln Gly Gly Arg Pro Leu Leu Gly Ile Arg
    130                 135                 140
Ile Gly Asn Asp Ala Phe Phe Thr Ala His Ala Ile Ala Met Arg Asn
145                 150                 155                 160
Asn Asp Ala Pro Ala Leu Val Glu Glu Val Tyr Asn Phe Phe Arg Asp
                165                 170                 175
Ser Arg Asp Pro Val His Gln Ala Leu Asn Trp Met Ile Leu Gly Asp
            180                 185                 190
Phe Asn Arg Glu Pro Ala Asp Leu Glu Met Asn Leu Thr Val Pro Val
        195                 200                 205
Arg Arg Ala Ser Glu Ile Ile Ser Pro Ala Ala Ala Thr Gln Thr Ser
    210                 215                 220
Gln Arg Thr Leu Asp Tyr Ala Val Ala Gly Asn Ser Val Ala Phe Arg
225                 230                 235                 240
Pro Ser Pro Leu Gln Ala Gly Ile Val Tyr Gly Ala Arg Arg Thr Gln
                245                 250                 255
Ile Ser Ser Asp His Phe Pro Val Gly Val Ser Arg Arg Gly Gly Gly
            260                 265                 270
Gly Gly Ile Thr Pro His Cys Arg Glu Ile Arg Ile Gly Ile Ala Gly
        275                 280                 285
Ile Thr Ile Thr Leu Ser Leu Cys Gly Cys Ala Asn Ala Arg Ala Pro
    290                 295                 300
Thr Leu Arg Ser Ala Thr Ala Asp Asn Ser Glu Ser Thr Gly Phe Lys
305                 310                 315                 320
Asn Val Pro Asp Leu Arg Thr Asp Gln Pro Lys Pro Pro Ser Lys Lys
                325                 330                 335
Arg Ser Cys Asp Pro Ser Glu Tyr Arg Val Ser Glu Leu Lys Glu Ser
            340                 345                 350
Leu Ile Thr Thr Thr Pro Ser Arg Pro Arg Thr Ala Lys Arg Arg Ile
        355                 360                 365
Arg Leu
    370
</s400>
<s200>
<s210>54</s210>
<s211>288</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CHIMERIC PROTEIN CYTOLETHAL DISTINDING TOXIN
      CLTDB FUSION WITH A TRUNCATED APOPTIN</s223>
</s220>
</s200>
<s400> 54
Met Lys Lys Tyr Ile Ile Ser Leu Ile Val Phe Leu Ser Phe Tyr Ala
1               5                   10                  15
Gln Ala Asp Leu Thr Asp Phe Arg Val Ala Thr Trp Asn Leu Gln Gly
            20                  25                  30
Ala Ser Ala Thr Thr Glu Ser Lys Trp Asn Ile Asn Val Arg Gln Leu
        35                  40                  45
Ile Ser Gly Glu Asn Ala Val Asp Ile Leu Ala Val Gln Glu Ala Gly
    50                  55                  60
Ser Pro Pro Ser Thr Ala Val Asp Thr Gly Thr Leu Ile Pro Ser Pro
65                  70                  75                  80
Gly Ile Pro Val Arg Glu Leu Ile Trp Asn Leu Ser Thr Asn Ser Arg
                85                  90                  95
Pro Gln Gln Val Tyr Ile Tyr Phe Ser Ala Val Asp Ala Leu Gly Gly
            100                 105                 110
Arg Val Asn Leu Ala Leu Val Ser Asn Arg Arg Ala Asp Glu Val Phe
        115                 120                 125
Val Leu Ser Pro Val Arg Gln Gly Gly Arg Pro Leu Leu Gly Ile Arg
    130                 135                 140
Ile Gly Asn Asp Ala Phe Phe Thr Ala His Ala Ile Ala Met Arg Asn
145                 150                 155                 160
Asn Asp Ala Pro Ala Leu Val Glu Glu Val Tyr Asn Phe Phe Arg Asp
                165                 170                 175
Ser Arg Asp Pro Val His Gln Ala Leu Asn Trp Met Ile Leu Gly Asp
            180                 185                 190
Phe Asn Arg Glu Pro Ala Asp Leu Glu Met Asn Leu Thr Val Pro Val
        195                 200                 205
Arg Arg Ala Ser Glu Ile Ile Ser Pro Ala Ala Ala Thr Gln Thr Ser
    210                 215                 220
Gln Arg Thr Leu Asp Tyr Ala Val Ala Gly Asn Ser Val Ala Phe Arg
225                 230                 235                 240
Pro Ser Pro Leu Gln Ala Gly Ile Val Tyr Gly Ala Arg Arg Thr Gln
                245                 250                 255
Ile Ser Ser Asp His Phe Pro Val Gly Val Ser Arg Arg Gly Gly Gly
            260                 265                 270
Gly Gly Ile Arg Ile Gly Ile Ala Gly Ile Thr Ile Thr Leu Ser Leu
        275                 280                 285
</s400>
<s200>
<s210>55</s210>
<s211>318</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>CHIMERIC PROTEIN CYTOLETHAL DISTINDING TOXIN
      CLTDB FUSION WITH A TRUNCATED APOPTIN</s223>
</s220>
</s200>
<s400> 55
Met Lys Lys Tyr Ile Ile Ser Leu Ile Val Phe Leu Ser Phe Tyr Ala
1               5                   10                  15
Gln Ala Asp Leu Thr Asp Phe Arg Val Ala Thr Trp Asn Leu Gln Gly
            20                  25                  30
Ala Ser Ala Thr Thr Glu Ser Lys Trp Asn Ile Asn Val Arg Gln Leu
        35                  40                  45
Ile Ser Gly Glu Asn Ala Val Asp Ile Leu Ala Val Gln Glu Ala Gly
    50                  55                  60
Ser Pro Pro Ser Thr Ala Val Asp Thr Gly Thr Leu Ile Pro Ser Pro
65                  70                  75                  80
Gly Ile Pro Val Arg Glu Leu Ile Trp Asn Leu Ser Thr Asn Ser Arg
                85                  90                  95
Pro Gln Gln Val Tyr Ile Tyr Phe Ser Ala Val Asp Ala Leu Gly Gly
            100                 105                 110
Arg Val Asn Leu Ala Leu Val Ser Asn Arg Arg Ala Asp Glu Val Phe
        115                 120                 125
Val Leu Ser Pro Val Arg Gln Gly Gly Arg Pro Leu Leu Gly Ile Arg
    130                 135                 140
Ile Gly Asn Asp Ala Phe Phe Thr Ala His Ala Ile Ala Met Arg Asn
145                 150                 155                 160
Asn Asp Ala Pro Ala Leu Val Glu Glu Val Tyr Asn Phe Phe Arg Asp
                165                 170                 175
Ser Arg Asp Pro Val His Gln Ala Leu Asn Trp Met Ile Leu Gly Asp
            180                 185                 190
Phe Asn Arg Glu Pro Ala Asp Leu Glu Met Asn Leu Thr Val Pro Val
        195                 200                 205
Arg Arg Ala Ser Glu Ile Ile Ser Pro Ala Ala Ala Thr Gln Thr Ser
    210                 215                 220
Gln Arg Thr Leu Asp Tyr Ala Val Ala Gly Asn Ser Val Ala Phe Arg
225                 230                 235                 240
Pro Ser Pro Leu Gln Ala Gly Ile Val Tyr Gly Ala Arg Arg Thr Gln
                245                 250                 255
Ile Ser Ser Asp His Phe Pro Val Gly Val Ser Arg Arg Gly Gly Gly
            260                 265                 270
Gly Gly Thr Asp Gln Pro Lys Pro Pro Ser Lys Lys Arg Ser Cys Asp
        275                 280                 285
Pro Ser Glu Tyr Arg Val Ser Glu Leu Lys Glu Ser Leu Ile Thr Thr
    290                 295                 300
Thr Pro Ser Arg Pro Arg Thr Ala Lys Arg Arg Ile Arg Leu
305                 310                 315
</s400>
<s200>
<s210>56</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>SEQUENCE ASSOCIATED WITH DIMERIZATION AND
      INACTIVATION</s223>
</s220>
</s200>
<s400> 56
Phe Arg Asp Ser Arg Asp Pro Val His Gln Ala Leu
1               5                   10
</s400>
<s200>
<s210>57</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN CLEAVAGE SITE</s223>
</s220>
</s200>
<s400> 57
Arg Xaa Arg Ala Lys Arg
1               5
</s400>
<s200>
<s210>58</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>HAEMOPHILUS LOOP ASSOCIATED WITH STABLE
      RETENTION OF CYTOTOXICITY</s223>
</s220>
</s200>
<s400> 58
Asn Ser Ser Ser Ser Pro Pro Glu Arg Arg Val Tyr
1               5                   10
</s400>
<s200>
<s210>59</s210>
<s211>33</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>GASTRIN-34 (BIG GASTRIN)</s223>
</s220>
</s200>
<s400> 59
Leu Gly Pro Gln Gly Pro Pro His Leu Val Ala Asp Pro Ser Lys Lys
1               5                   10                  15
Gln Gly Pro Trp Leu Glu Glu Glu Glu Glu Ala Tyr Gly Trp Met Asp
            20                  25                  30
Phe
</s400>
<s200>
<s210>60</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>FURIN INHIBITOR</s223>
</s220>
</s200>
<s400> 60
Gly Lys Arg Pro Arg Ala Lys Arg Ala
1               5
</s400>
</sequence-list-new-rules>
</sequence-cwu>
